microRNAs in liver and kidney ischemia reperfusion injury: insight to improve transplantation outcome - 19/12/20
pages | 9 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | Ischemia reperfusion injury (IRI) is often associated with microvascular dysfunction. |
• | Production and release of inflammatory mediators in IRI leads to tissue damage, especially during organ transplantation. |
• | MicroRNAs (miRs) as genetic regulators, might attenuate or ameliorate this status. |
• | Nowadays miRs has potential to be used as biomarkers and therapeutic agents. |
Abstract |
Ischemia reperfusion injury (IRI) is a condition that occurs wherever blood flow and oxygen is reduced or absent, such as trauma, vascular disease, stroke, and solid organ transplantation. This condition can lead to tissue damage, especially during organ transplantation. Under such circumstances, some signaling pathways are activated, leading to up- or down- regulation of several genes such as microRNAs (miRNAs) that might attenuate or ameliorate this status. Therefore, by manipulating miRNAs level, they can be used as a biomarker for early diagnosis of IRI or suggestive to be therapeutic agents in clinical situation in future.
Le texte complet de cet article est disponible en PDF.Keywords : Kidney, Ischemia reperfusion injury, Liver, microRNAs, Transplantation
Plan
Vol 133
Article 110944- janvier 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?